Cellectar Biosciences, Inc. (CLRB) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CLRB Revenue Growth
CLRB Revenue Analysis (2014–2025)
As of May 8, 2026, Cellectar Biosciences, Inc. (CLRB) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, CLRB's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including PRTC (-53.7% YoY), RNAC (-94.8% YoY), and RMD (+10.3% YoY). Compare CLRB vs PRTC →
CLRB Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CLRBCurrent | $0 | - | - | - | |
 PRTC | $5M | -53.7% | -11.0% | -2114.7% | |
 RNAC | $3M | -94.8% | -30.0% | -3099.9% | |
 RMD | $5.1B | +10.3% | +11.7% | 32.7% | |
 AGEN | $114M | +10.4% | +5.3% | -18.0% |
CLRB Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-213,597 | - | $-22,979,844 | - |
| 2024 | $0 | - | $0 | - | $-51,777,698 | - |
| 2023 | $0 | - | $0 | - | $-38,960,643 | - |
| 2022 | $0 | - | $0 | - | $-28,813,773 | - |
| 2021 | $0 | - | $0 | - | $-24,131,280 | - |
| 2020 | $0 | - | $0 | - | $-15,290,349 | - |
| 2019 | $0 | - | $-189,360 | - | $-14,178,624 | - |
| 2018 | $0 | - | $-82,265 | - | $-13,330,764 | - |
| 2017 | $0 | - | $-1,546,048 | - | $-13,600,970 | - |
| 2016 | $0 | - | $-356,665 | - | $-9,449,752 | - |
See CLRB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CLRB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CLRB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCLRB — Frequently Asked Questions
Quick answers to the most common questions about buying CLRB stock.
Is CLRB's revenue growth accelerating or slowing?
CLRB TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is CLRB's long-term revenue growth rate?
Cellectar Biosciences, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is CLRB's revenue distributed by segment?
CLRB reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.